Insomnia Drug Market To Exceed $5.6 Billion In 2013

Direct-To-Consumer Marketing Will Play A Key Role in Expanding the Market, According to a New Study from Decision Resources

August 16, 2004–Waltham, Mass.--Decision Resources, Inc., one of the world’s leading research and advisory firms focusing on pharmaceutical and health care issues, forecasts that the insomnia drug market will exceed $5.6 billion in 2013. The new Pharmacor study entitled Insomnia finds that upcoming launches of three new drugs from Sepracor, Pfizer, and Sanofi-Aventis will drive the market.

< BACK